| PERIOD ENDING | 31-Mar-09 | 31-Mar-08 | 31-Mar-07 | | Total Revenue | 122,879 | 101,346 | 95,130 | | Cost of Revenue | 31,284 | 26,189 | 20,529 | | | Gross Profit | 91,595 | 75,157 | 74,601 | | | Operating Expenses | | Research Development | 30,791 | 27,471 | 21,688 | | Selling General and Administrative | 54,390 | 51,104 | 45,127 | | Non Recurring |
-
|
-
|
-
| | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 6,414 | (3,418) | 7,786 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1,271 | 3,610 | 3,860 | | Earnings Before Interest And Taxes | 7,685 | 192 | 11,646 | | Interest Expense | 25 | 31 | 26 | | Income Before Tax | 7,660 | 161 | 11,620 | | Income Tax Expense | 2,928 | (372) | 3,655 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 4,732 | 533 | 7,965 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 4,732 | 533 | 7,965 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,732 | $533 | $7,965 |
|
1.48% Nasdaq 
Income Statement
